// health tech

All signals tagged with this topic

Injectable device controls nerves wirelessly to treat chronic pain

Researchers have demonstrated a fundamentally different approach to neuromodulation—moving from implanted pacemaker-like devices toward injectable, batteryless systems that respond to external stimulation. Chronic pain affects 100+ million Americans; current treatments require either major surgery or continuous pharmaceutical management. A minimally invasive alternative could reduce barriers to access. The absence of batteries and wires also eliminates the infection risk and replacement procedures that plague existing implants, which is why this approach could accelerate adoption across pain management, movement disorders, and other conditions requiring precise neural intervention.

RFK Jr. opens door to peptide telehealth boom

Kennedy's regulatory push to relax peptide restrictions creates a direct commercial opportunity for telehealth platforms like GoodRx and Ro, which have already built infrastructure to distribute compounded medications at scale. The move mirrors how ketamine clinics and GLP-1 distribution networks captured consumer spend by operating in regulatory gray zones—except peptides, used for muscle building and anti-aging, appeal to a broader wellness market than psychiatric or weight-loss drugs. If peptides move from black-market fitness supplements to FDA-adjacent telehealth products, the winner is not the wellness industry broadly but the companies with existing prescriber networks and patient data that can convert curiosity into recurring revenue.